tradingkey.logo

Sensei Biotherapeutics Inc <SNSE.OQ> expected to post a loss of 22 cents a share - Earnings Preview

ReutersMay 5, 2025 12:49 PM
  • Sensei Biotherapeutics Inc SNSE.OQ SNSE.O is expected to show no change in quarterly revenue when it reports results on May 7 (estimated) for the period ending March 31 2025

  • ​LSEG's mean analyst estimate for Sensei Biotherapeutics Inc is for a loss of 22 cents per share.

  • The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts had risen by about 2.1% in the last three months. ​

  • Wall Street's median 12-month price target for Sensei Biotherapeutics Inc is $4.00​, above​ its last closing price of $0.42. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Dec. 31 2024

-0.29

-0.28

-0.31

Missed

-12

Sep. 30 2024

-0.31

-0.31

-0.29

Beat

7.2

Jun. 30 2024

-0.30

-0.29

-0.28

Beat

2.9​

Mar. 31 2024

-0.27

-0.27

-0.32

Missed

-16.4

​​Dec. 31 2023

-0.31

-0.31

-0.30

Beat

2.5

Sep. 30 2023

-0.34

-0.34

-0.28

Beat

17.4​

Jun. 30 2023

-0.33

-0.33

-0.31

Beat

6.2

Mar. 31 2023

-0.36

-0.36

-0.33

Beat

7.3

This summary was machine generated May 5 at 12:49 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI